UNSPSC 51111644: Lonidamine

This classification denotes a radiosensitizing agent and multidrug resistance modulator with the molecular formula C15H10Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U78804BIDR, chemically known as 1h-indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)- (9ci) but generally known as lonidamine, which bears US NIH Compound Identifier 39562. European Medicines Agency schedules Lonidamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08571MIG.

UNSPSC 51111644 Lonidamine is a Commodity-tier code for a specific pharmaceutical active ingredient with extremely limited state and local procurement activity. The source provides no recent state and local contract opportunities soliciting this product.

Lonidamine is a mitochondrial function modulator used in oncology and other therapeutic contexts, but state and local governments — which typically procure pharmaceuticals through established group purchasing organizations, state health department bulk purchasing programs, or managed care formularies rather than direct solicitation — show no recent RFP, RFQ, IFB, or ITB activity under this code. Without documented recent opportunities, no issuing-body mix, geographic concentration, or representative solicitations can be characterized from state and local procurement records.